UCNP-based Photoluminescent Nanomedicines for Targeted Imaging and Theranostics of Cancer

Molecules. 2020 Sep 19;25(18):4302. doi: 10.3390/molecules25184302.

Abstract

Theranostic approach is currently among the fastest growing trends in cancer treatment. It implies the creation of multifunctional agents for simultaneous precise diagnosis and targeted impact on tumor cells. A new type of theranostic complexes was created based on NaYF4: Yb,Tm upconversion nanoparticles coated with polyethylene glycol and functionalized with the HER2-specific recombinant targeted toxin DARPin-LoPE. The obtained agents bind to HER2-overexpressing human breast adenocarcinoma cells and demonstrate selective cytotoxicity against this type of cancer cells. Using fluorescent human breast adenocarcinoma xenograft models, the possibility of intravital visualization of the UCNP-based complexes biodistribution and accumulation in tumor was demonstrated.

Keywords: antigen; drug; imaging; immunoconjugates; therapy; tumor.

MeSH terms

  • Animals
  • Breast Neoplasms / diagnostic imaging
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Female
  • Fluorescent Dyes / chemistry
  • Fluorides / chemistry
  • Humans
  • Metal Nanoparticles / chemistry*
  • Metal Nanoparticles / therapeutic use
  • Metal Nanoparticles / toxicity
  • Mice
  • Mice, Nude
  • Polyethylene Glycols / chemistry
  • Receptor, ErbB-2 / metabolism
  • Theranostic Nanomedicine*
  • Thulium / chemistry
  • Transplantation, Heterologous
  • Ytterbium / chemistry
  • Yttrium / chemistry

Substances

  • Fluorescent Dyes
  • sodium yttriumtetrafluoride
  • Polyethylene Glycols
  • Yttrium
  • Thulium
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Ytterbium
  • Fluorides